Skip to main content

Thermo s Revenues Grow 7 Percent in Q1; Profit Jumps 13 Percent

NEW YORK, April 27 (GenomeWeb News) - Thermo Electron today reported a 7-percent increase in revenues and a 13-percent jump in earnings for the first quarter of 2005.


Revenues for the three month period ended March 31 grew to $559.2 million from $525 million during the same period in 2004. Most of this increase resulted from acquisitions, according to the company. Thermo's Life and Laboratory Sciences unit, which also sells mass spectrometers for proteomics, had $393.3 million in revenues, an 8-percent increase from $365.5 million during the year-ago quarter.


R&D expenses in the period almost doubled to $7.4 million from $3.8 million during last year's first quarter.


Thermo's net income for the quarter grew to $48.9 million, or $.30 per share, up from $43.1 million, or $.26 per share, during the same quarter last year.


As of April 2, Thermo had $351.6 million in cash and cash equivalents, and $177 million in short-term available-for-sale investments.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.